Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes.
Andrew P Morris, Benjamin F Voight, Tanya M Teslovich, Teresa Ferreira, Ayellet V Segrè, Valgerdur Steinthorsdottir, Rona J Strawbridge, Hassan Khan, Harald Grallert, Anubha Mahajan and 200 more
Synthesis in Nature genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,199 papers, 14 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
1,199citing papers in PubMed, 14 pooled it
113.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1,199 citing papers in PubMed, 14 syntheses or guidelines pooled it, 2,003 citations in OpenAlex.
1,139 more citing papers are in PubMed but not listed here.
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
210 authors at 20 institutions in 18 countries.
Andrew P MorrisWellcome Trust Centre for Human Genetics, University of Oxford, UK. amorris@well.ox.ac.uk
Benjamin F Voight
Tanya M Teslovich
Teresa Ferreira
Ayellet V Segrè
Valgerdur Steinthorsdottir
Rona J Strawbridge
Hassan Khan
Harald Grallert
Anubha Mahajan
Inga Prokopenko
Hyun Min Kang
Christian Dina
Tonu Esko
Ross M Fraser
Stavroula Kanoni
Ashish Kumar
Vasiliki Lagou
Claudia Langenberg
Jian'an Luan
Cecilia M Lindgren
Martina Müller-Nurasyid
Sonali Pechlivanis
N William Rayner
Laura J Scott
Steven Wiltshire
Loic Yengo
Leena Kinnunen
Elizabeth J Rossin
Soumya Raychaudhuri
Andrew D Johnson
Antigone S Dimas
Ruth J F Loos
Sailaja Vedantam
Han Chen
Jose C Florez
Caroline Fox
Ching-Ti Liu
Denis Rybin
David J Couper
Wen Hong L Kao
Man Li
Marilyn C Cornelis
Peter Kraft
Qi Sun
Rob M van Dam
Heather M Stringham
Peter S Chines
Krista Fischer
Pierre Fontanillas
Oddgeir L Holmen
Sarah E Hunt
Anne U Jackson
Augustine Kong
Robert Lawrence
Julia Meyer
John R B Perry
Carl G P Platou
Simon Potter
Emil Rehnberg
Neil Robertson
Suthesh Sivapalaratnam
Alena Stančáková
Kathleen Stirrups
Gudmar Thorleifsson
Emmi Tikkanen
Andrew R Wood
Peter Almgren
Mustafa Atalay
Rafn Benediktsson
Lori L Bonnycastle
Noël Burtt
Jason Carey
Guillaume Charpentier
Andrew T Crenshaw
Alex S F Doney
Mozhgan Dorkhan
Sarah Edkins
Valur Emilsson
Elodie Eury
Tom Forsen
Karl Gertow
Bruna Gigante
George B Grant
Christopher J Groves
Candace Guiducci
Christian Herder
Astradur B Hreidarsson
Jennie Hui
Alan James
Anna Jonsson
Wolfgang Rathmann
Norman Klopp
Jasmina Kravic
Kaarel Krjutškov
Cordelia Langford
Karin Leander
Eero Lindholm
Stéphane Lobbens
Satu Männistö
Ghazala Mirza
Thomas W Mühleisen
Bill Musk
Melissa Parkin
Loukianos Rallidis
Jouko Saramies
Bengt Sennblad
Sonia Shah
Gunnar Sigurðsson
Angela Silveira
Gerald Steinbach
Barbara Thorand
Joseph Trakalo
Fabrizio Veglia
Roman Wennauer
Wendy Winckler
Delilah Zabaneh
Harry Campbell
Cornelia van Duijn
Andre G Uitterlinden
Albert Hofman
Eric Sijbrands
Goncalo R Abecasis
Katharine R Owen
Eleftheria Zeggini
Mieke D Trip
Nita G Forouhi
Ann-Christine Syvänen
Johan G Eriksson
Leena Peltonen
Markus M Nöthen
Beverley Balkau
Colin N A Palmer
Valeriya Lyssenko
Tiinamaija Tuomi
Bo Isomaa
David J Hunter
Lu Qi
Wellcome Trust Case Control Consortium
Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators
Genetic Investigation of ANthropometric Traits (GIANT) Consortium
Asian Genetic Epidemiology Network–Type 2 Diabetes (AGEN-T2D) Consortium
South Asian Type 2 Diabetes (SAT2D) Consortium
Alan R Shuldiner
Michael Roden
Ines Barroso
Tom Wilsgaard
John Beilby
Kees Hovingh
Jackie F Price
James F Wilson
Rainer Rauramaa
Timo A Lakka
Lars Lind
George Dedoussis
Inger Njølstad
Nancy L Pedersen
Kay-Tee Khaw
Nicholas J Wareham
Sirkka M Keinanen-Kiukaanniemi
Timo E Saaristo
Eeva Korpi-Hyövälti
Juha Saltevo
Markku Laakso
Johanna Kuusisto
Andres Metspalu
Francis S Collins
Karen L Mohlke
Richard N Bergman
Jaakko Tuomilehto
Bernhard O Boehm
Christian Gieger
Kristian Hveem
Stephane Cauchi
Philippe Froguel
Damiano Baldassarre
Elena Tremoli
Steve E Humphries
Danish Saleheen
John Danesh
Erik Ingelsson
Samuli Ripatti
Veikko Salomaa
Raimund Erbel
Karl-Heinz Jöckel
Susanne Moebus
Annette Peters
Thomas Illig
Ulf de Faire
Anders Hamsten
Andrew D Morris
Peter J Donnelly
Timothy M Frayling
Andrew T Hattersley
Eric Boerwinkle
Olle Melander
Sekar Kathiresan
Peter M Nilsson
Panos Deloukas
Unnur Thorsteinsdottir
Leif C Groop
Kari Stefansson
Frank Hu
James S Pankow
Josée Dupuis
James B Meigs
David Altshuler
Michael Boehnke
Mark I McCarthy
DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium
Broad Institute · USCentre for Human Genetics · GBScania (Sweden) · SEWellcome Sanger Institute · GBHelmholtz Zentrum München · DEUniversity of Michigan · USCentre National de la Recherche Scientifique · FRKarolinska Institutet · SEUniversity of Eastern Finland · FIBrigham and Women's Hospital · USdeCODE Genetics (Iceland) · ISFinnish Institute for Health and Welfare · FIKarolinska University Hospital · SEThe University of Western Australia · AUUniversity of Cambridge · GBAddenbrooke's Hospital · GBBoston University · USErasmus MC · NLHarvard University · USUniversity of Tartu · EE
Funding
Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Validity of Diet and Activity Measures in WomenP01CA055075 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI FUCHS, CHARLES S · 1991 to 2009
$41.8M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Genome-Wide Association Analysis in Essential Hypertension (FEHGAS study)R01HL086694 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARAVINDA CHAKRAVARTI · 2007 to 2026
$21.2M
MOUNT SINAI INSTITUTES FOR CLINICAL AND TRANSLATIONAL SCIENCESUL1RR029887 · NCRR · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SAMPSON, HUGH A · 2009 to 2011
$19.2M
University of Michigan Training Program in Genomic ScienceT32HG000040 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sebastian Zoellner · 1995 to 2026
$16.4M
Epidemiology of Venous Thrombosis & Pulmonary EmbolismR01HL059367 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI TANG, WEIHONG · 1998 to 2024
$11.8M
Identifying Genes for Type 2 Diabetes: FUSIONU01DK062370 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L, SCOTT, LAURA J. · 2009 to 2021
$11.6M
Targeted Genetic Analysis of T2D and Quantitative TraitsR01DK072193 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN L. MOHLKE · 2005 to 2026
$11.3M
SNP HEALTH ASSOCIATION RESOURCE (SHARE)N02HL64278 · NHLBI · PI CHIN, SIANG · 2007 to 2007
$9.2M
Genetic epidemiology of rare and regulatory variants for metabolic traitsR01DK093757 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN L. MOHLKE · 2011 to 2026
$8.2M
British Heart Foundation RG/07/008/23674British Heart Foundation RG/08/008/25291British Heart Foundation RG/08/014/24067British Heart Foundation RG2008/08British Heart Foundation RG/98002Cancer Research UKChief Scientist Office CZB/4/672Chief Scientist Office CZB/4/710Department of Health DHCS/07/07/008Intramural NIH HHS Z01 HG000024Medical Research Council G0000649Medical Research Council G0100222Medical Research Council G0401527Medical Research Council G0600717Medical Research Council G0601261Medical Research Council G0701863Medical Research Council G0902037Medical Research Council G1000143Medical Research Council G19/35Medical Research Council G8802774Medical Research Council MC_PC_U127561128Medical Research Council MC_U106179471Medical Research Council MC_UP_A100_1003NCI NIH HHS CA055075NCI NIH HHS P01 CA055075NCRR NIH HHS UL1 RR025005NCRR NIH HHS UL1RR025005NCRR NIH HHS UL1 RR029887NHGRI NIH HHS 1Z01HG000024NHGRI NIH HHS N01 HG065403NHGRI NIH HHS T32 HG000040NHGRI NIH HHS U01 HG004399NHGRI NIH HHS U01HG004399NHGRI NIH HHS U01 HG004402NHGRI NIH HHS U01HG004402NHGRI NIH HHS U01 HG006513NHLBI NIH HHS HHSN268201100005CNHLBI NIH HHS HHSN268201100005GNHLBI NIH HHS HHSN268201100005INHLBI NIH HHS HHSN268201100006CNHLBI NIH HHS HHSN268201100007CNHLBI NIH HHS HHSN268201100007INHLBI NIH HHS HHSN268201100008CNHLBI NIH HHS HHSN268201100008INHLBI NIH HHS HHSN268201100009CNHLBI NIH HHS HHSN268201100009INHLBI NIH HHS HHSN268201100010CNHLBI NIH HHS HHSN268201100011CNHLBI NIH HHS HHSN268201100011INHLBI NIH HHS HHSN268201100012CNHLBI NIH HHS N01 HC025195NHLBI NIH HHS N02HL64278NHLBI NIH HHS R01 HL059367NHLBI NIH HHS R01 HL086694NHLBI NIH HHS R01HL086694NHLBI NIH HHS R01 HL087641NHLBI NIH HHS R01HL087641NHLBI NIH HHS R01HL59367NIA NIH HHS AG028555NIA NIH HHS AG04563NIA NIH HHS AG08724NIA NIH HHS AG08861NIA NIH HHS AG10175NIA NIH HHS R01 AG008724NIA NIH HHS R01 AG010175NIA NIH HHS R01 AG028555NIDDK NIH HHS DK058845NIDDK NIH HHS DK062370NIDDK NIH HHS DK072193NIDDK NIH HHS DK073490NIDDK NIH HHS DK078616NIDDK NIH HHS DK080140NIDDK NIH HHS K24 DK080140NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK058845NIDDK NIH HHS R01 DK062370NIDDK NIH HHS R01 DK072193NIDDK NIH HHS R01 DK073490NIDDK NIH HHS R01 DK078616NIDDK NIH HHS R01 DK093757NIDDK NIH HHS R56 DK062370NIDDK NIH HHS U01 DK062370NIDDK NIH HHS U01 DK078616NIDDK NIH HHS U01 DK085545NIDDK NIH HHS UM1 DK078616NIGMS NIH HHS T32 GM007753NINDS NIH HHS 1R21NS064908NINDS NIH HHS R21 NS064908Wellcome Trust 064890Wellcome Trust 081682Wellcome Trust 090367Wellcome Trust 090532Wellcome Trust 098017Wellcome Trust GR072960Wellcome Trust GR076113Wellcome Trust GR077016Wellcome Trust GR081682Wellcome Trust GR083270Wellcome Trust GR083948Wellcome Trust GR084711Wellcome Trust GR086596Wellcome Trust GR090532Wellcome Trust GR098051
6 · The paper itself
Abstract
To extend understanding of the genetic architecture and molecular basis of type 2 diabetes (T2D), we conducted a meta-analysis of genetic variants on the Metabochip, including 34,840 cases and 114,981 controls, overwhelmingly of European descent. We identified ten previously unreported T2D susceptibility loci, including two showing sex-differentiated association. Genome-wide analyses of these data are consistent with a long tail of additional common variant loci explaining much of the variation in susceptibility to T2D. Exploration of the enlarged set of susceptibility loci implicates several processes, including CREBBP-related transcription, adipocytokine signaling and cell cycle regulation, in diabetes pathogenesis.
Indexed as
Genetic Predisposition to DiseaseCase-Control StudiesDiabetes Mellitus, Type 2FemaleGenesGenome-Wide Association StudyHumansLinkage DisequilibriumMalePakistanPolymorphism, Single NucleotideSex Factors
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. · full record | OpenQuestion